Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa

Clicks: 351
ID: 273530
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #30 of 102 articles by views in plos neglected tropical diseases

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Author summary Loa loa (the parasite causing loiasis), also known as African eye worm, is endemic in forest areas of west and central Africa. In several of the endemic areas, it co-exists with onchocerciasis and lymphatic filariasis (LF). Because of the benefit individuals suffering from onchocerciasis could have by taking ivermectin where the disease is severe, despite the risk of developing serious side-effects due to being co-infected with L. loa, mass drug administration (MDA) of ivermectin for the control of onchocerciasis has been ongoing in areas where the two diseases overlap. Ivermectin is also effective against loiasis. It is, therefore, hypothesized that several years of ivermectin MDA against onchocerciasis in those areas may have impacted on parasitological indicators for loiasis. In particular, we assess the impact of annual community directed treatment with ivermectin (CDTI) on loiasis with specific reference to the relationship between adherence to treatment and the risk of developing severe (nervous system) complications following ivermectin treatment. We also discuss the feasibility of eliminating onchocerciasis and/or LF in areas endemic for L. loa with ivermectin as the sole intervention tool.
Reference Key
wanji2018plosimpact Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Samuel Wanji;Winston Patrick Chounna Ndongmo;Fanny Fri Fombad;Jonas Arnaud Kengne-Ouafo;Abdel Jelil Njouendou;Yolande Flore Longang Tchounkeu;Benjamin Koudou;Moses Bockarie;Grace Fobi;Jean Baptiste Roungou;Peter A. Enyong;
Journal plos neglected tropical diseases
Year 2018
DOI
10.1371/journal.pntd.0006750
URL
http://dx.doi.org/10.1371/journal.pntd.0006750
Keywords
blood seasons onchocerciasis parasitic diseases parasitology medical risk factors loa loa loiasis

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.